{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT01808638: Phase 1/Phase 2 Interventional Completed Carcinoma, Pancreatic Ductal
(2013)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:trabedersen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:olaptesed pegol [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02500381: Phase 3 Interventional Active, not recruiting Duchenne Muscular Dystrophy
(2016)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:pegnivacogin [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00002403: Phase 1 Interventional Completed HIV Infections
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:pegpleranib [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00565058: Phase 2 Interventional Completed Acute Myeloid Leukemia
(2007)
Source URL:
Class:
NUCLEIC ACID